Acetaminophen (Paracetamol) is the ONLY Recommended Antipyretic and Analgesic for Pediatric Dengue
For children with dengue, use acetaminophen (paracetamol) at 10-15 mg/kg/dose every 4-6 hours (maximum 60-75 mg/kg/day, not exceeding 4 grams/day in adolescents). NSAIDs including ibuprofen, aspirin, and other anti-inflammatory agents are contraindicated due to bleeding risk associated with dengue-related thrombocytopenia.
Dosing Algorithm for Acetaminophen in Pediatric Dengue
Weight-based dosing (preferred):
- 10-15 mg/kg per dose
- Administer every 4-6 hours as needed
- Maximum daily dose: 60-75 mg/kg/day
- Do not exceed 4 grams/day in adolescents
Age-based dosing (when weight unknown):
- 0-3 months: 40 mg per dose
- 4-11 months: 80 mg per dose
- 1-2 years: 120 mg per dose
- 2-3 years: 160 mg per dose
- 4-5 years: 240 mg per dose
- 6-8 years: 320 mg per dose
- 9-10 years: 400 mg per dose
- 11-12 years: 480 mg per dose
- ≥12 years: 650-1000 mg per dose
Why NSAIDs Are Absolutely Contraindicated
The traditional contraindication against NSAIDs in dengue stems from the risk of exacerbating bleeding complications in patients who develop thrombocytopenia and coagulopathy. While recent research 1 suggests that low-dose ibuprofen may have comparable safety to acetaminophen in non-severe dengue, and another analysis 2 questions the blanket NSAID contraindication, these studies are insufficient to overturn established guidelines.
The critical issue is that dengue severity can evolve rapidly during the "critical phase" (typically days 3-7 of illness), when plasma leakage and hemorrhagic manifestations may suddenly develop. A child initially classified as having non-severe dengue can deteriorate within hours. The antiplatelet effects of NSAIDs persist for days, creating an unacceptable risk window.
Important Clinical Caveats
Hepatotoxicity concerns with acetaminophen: While acetaminophen is the recommended agent, clinicians must be aware that dengue itself frequently causes hepatitis 2. Monitor liver function tests, and reduce acetaminophen dosing or discontinue if significant transaminase elevation occurs (ALT/AST >1000 IU/L or signs of hepatic dysfunction). The standard maximum daily dose should be reduced by 50% in patients with pre-existing liver disease.
Avoid combination or alternating regimens: Although combined or alternating acetaminophen-ibuprofen regimens are sometimes used for fever in otherwise healthy children 3, this approach is not appropriate for dengue due to the NSAID component. Do not alternate acetaminophen with any NSAID.
Aspirin is absolutely contraindicated: Aspirin carries the highest bleeding risk among NSAIDs and is never appropriate in dengue, particularly in children where Reye's syndrome is an additional concern.
Monitoring and Supportive Care
Antipyretics are purely symptomatic treatment. The cornerstone of dengue management remains:
- Adequate hydration with isotonic fluids (avoid hypotonic solutions 4)
- Serial monitoring of platelet counts, hematocrit, and warning signs
- Recognition of the critical phase (typically when fever defervesces)
- Immediate escalation if warning signs develop (abdominal pain, persistent vomiting, mucosal bleeding, lethargy, hepatomegaly, rising hematocrit with falling platelets)
Platelet transfusion is not indicated prophylactically for thrombocytopenia alone; reserve for active bleeding or pre-procedural preparation 4.
Practical Implementation
- Start acetaminophen immediately for fever >38.5°C or significant discomfort
- Schedule around-the-clock dosing during febrile phase rather than PRN to maintain comfort
- Educate caregivers explicitly that ibuprofen, aspirin, and all NSAIDs are forbidden
- Provide written discharge instructions specifying acetaminophen dosing and listing prohibited medications
- Ensure follow-up during days 3-7 (critical phase) even if fever resolves
The evidence base for dengue-specific antipyretic studies remains limited, but the risk-benefit analysis clearly favors acetaminophen monotherapy over any NSAID-containing regimen in the pediatric dengue population.